Halogen compounds having thrombopoietin receptor agonism

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 277/46 (2006.01) A61K 31/427 (2006.01) A61K 31/428 (2006.01) A61K 31/429 (2006.01) A61K 31/4439 (2006.01) A61K 31/5377 (2006.01) A61P 7/02 (2006.01) A61P 7/04 (2006.01) A61P 43/00 (2006.01) C07D 277/60 (2006.01) C07D 277/84 (2006.01) C07D 417/14 (2006.01) C07D 513/04 (2006.01)

Patent

CA 2435143

Compounds represented by the following general formula (III), prodrugs thereof, pharmaceutically acceptable salts thereof or solvates of the same which have a thrombopoietin agonism: (III) wherein R9 represents hydrogen, optionally substituted lower alkyl, etc.; R10, R11 and R12 independently represent each optionally substituted alkyl, halogeno, etc.; R14s independently represent each lower alkyl, halogeno, etc.; n is an integer of 0 to 2; and the ring A3 is a group represented by the following formula: (wherein R13 represents hydrogen or lower alkyl; and T represents oxygen or sulfur).

La présente invention concerne des composés représentés par la formule (III), des précurseurs de médicament, des sels et des solvates pharmaceutiquement acceptables de ces derniers qui ont un agonisme envers la thrombopoïétine. Dans la formule, R?9¿ représente hydrogène, alkyle inférieur éventuellement substitué ou similaires; R?10¿, R?11¿ et R?12¿ représentent chacun indépendamment alkyle substitué, halogéno ou similaires; les R?14¿ représentent chacun indépendamment alkyle inférieur, halogéno ou similaires; n est un entier tel que 0, 1 ou 2 et le cycle A?3¿ est un groupe représenté par la formule (II), dans laquelle R?13¿ représente hydrogène ou alkyle inférieur et T représente oxygène ou soufre. Formules (II) et (III)

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Halogen compounds having thrombopoietin receptor agonism does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Halogen compounds having thrombopoietin receptor agonism, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Halogen compounds having thrombopoietin receptor agonism will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1362865

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.